(MENAFN- iCrowdNewsWire)Generally people that are suffering from common illness like cold, cough, headache, and others tend to use commonly-available non-prescription drugs within two days in order to cure the illness. The consumer healthcare products basically include the “over-the-counter” (OTC) drugs that are sold without a registered medical practitioner prescription. Consumers usually buy OTC consumer healthcare depending on famous brands. The products consists of analgesics, wound care, oral healthcare, medicated skin care, and others. The common illnesses prompt the use of oral healthcare product.
The “ Global OTC Consumer Healthcare Market Analysis to 2028 “ is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the OTC consumer healthcare market with detailed market segmentation by product, distribution channel, form, and geography. The report provides key statistics on the market status of the leading OTC consumer healthcare market players and offers key trends and opportunities in the market.
Get sample PDF Copy at:
OTC Consumer Healthcare MARKET PLAYERS
- Sun Pharmaceutical Industries Limited.
- GlaxoSmithKline Plc
- Glenmark Pharmaceuticals Ltd.
- Johnson & Johnson Private Ltd
- Sanofi S.A.
- Piramal Enterprises Ltd.
- Boehringer Ingelheim GmbH
- Bayer AG
- Ipsen SA
- Teva Pharmaceutical Industries Ltd
MARKET SEGMENTATION
- Based on product, the global OTC consumer healthcare market is segmented into OTC pharmaceuticals and dietary supplements.
- On the basis of distribution channel, the market is bifurcated into wholesalers & distributors, pharmacy or drug stores, specialty stores, online retailers, hypermarkets/supermarkets, and other.
- On the basis of form, the market is bifurcated into tablet, powder, liquid, and others.
Drivers
- Increasing popularity among customer, growing product awareness and increasing sales volume of OTC are the factors driving the OTC consumer healthcare market.
- Rising preferences for natural medicinal products & supplements, growing elderly population coupled with the high amount of common ailments among these people boosts the market growth.
- Growing analgesics adoption for pain and increasing product availability at pharmaceutical stores fuel the growth of the market.
- Increasing rate of local key players with extensive focus on research and development activities and various government initiative for promoting quality healthcare are expected to favor the market growth.
Restraints
- Abuse of OTC medications resulting in addiction and dependency.
- Inconsistent regulatory framework in various economies.
COVID-19 first began in Wuhan (China) during December 2019, and since then, it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, UK, Turkey, Italy, and Spain are some of the worst affected countries in terms of confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. The outbreak has created a lot of panic among the population due to which people are becoming more cautious and delay unnecessary visits to doctors and medical stores as much as possible inorder to practice social distancing measures to control the infection transmission. However, growing concern of consumers regarding the health resulted in increased sales of immunity boosters worldwide. Hence, it is estimated that the OTC consumer healthcare market may witness potential growth in the forecast period.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The OTC consumer healthcare market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
Buy Complete Report at:
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
MENAFN02062021003318003403ID1102195977
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.